Prognostic Value of CD200 Expression and Soluble CTLA-4 Concentrations in Intermediate and High-Risk Myelodysplastic Syndrome Patients.

Salah ArefMohamed El AgdarAhmed El SebaieTarek AbouzeidMohamed SabryLamiaa Ibrahim

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

CD200 positive expression could be considered as a new prognostic marker for risk stratification of MDS patients. CD200 expression may exert its effect through upregulation of CTLA-4.<br />.

Keyphrases

poor prognosis
end stage renal disease
ejection fraction
newly diagnosed
binding protein
cell proliferation
long non coding rna
nk cells